Yahoo
NasdaqCM - BOATS Real Time Price USD

Outlook Therapeutics, Inc. (OTLK)

0.4364 -0.0027 (-0.61%)
At close: November 6 at 4:00:01 PM EST
0.4750 +0.0386 (+8.85%)
Overnight: 2:12:32 AM EST
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements have been upgraded
A new layout with more detail in every statement.
TTM
9/30/2025
9/30/2024
9/30/2023
9/30/2022
Total Revenue
424.9280 1,413.5350 0 0 0
Cost of Revenue
-1,112.4330 -1,356.3300 0 -- --
Gross Profit
-2,275.9140 57.2050 0 -- --
Selling, General and Administrative Expenses
-35,995.1040 -39,938.2310 -29,940.1880 -26,673.4400 -20,739.8970
Research and Development Expenses
-17,364.7360 -27,180.6400 -41,763.0470 -26,452.9420 -42,330.8560
Operating Income/Expenses
-53,359.8400 -67,118.8710 -71,703.2350 -53,126.3820 -63,070.7530
Total Operating Profit/Loss
-55,635.7540 -67,061.6660 -71,703.2350 -53,126.3820 -63,070.7530
Total Net Finance Income/Expense
-174.4080 -193.3900 -2,250.8140 -1,559.7480 -1,487.4560
Net Investment Income
-472.2980 42,874.8240 38,537.3000 39.9210 417.0500
Irregular Income/Expenses
-1,043.4480 -- 0 -577.6590 -1,025.4020
Other Income/Expense, Non-Operating
-5,351.9770 -39,596.4600 -39,947.1650 -3,756 -882.9030
Non-Operating Income/Expenses, Total
-7,042.1310 3,084.9740 -3,660.6790 -5,853.4860 -2,978.7110
Pretax Income
-62,677.8850 -63,976.6920 -75,363.9140 -58,979.8680 -66,049.4640
Provision for Income Tax
1,554.6290 1,551.8290 -2.8000 -2.8000 -2.8000
Net Income from Continuing Operations
-61,123.2560 -62,424.8630 -75,366.7140 -58,982.6680 -66,052.2640
Net Income after Extraordinary Items and Discontinued Operations
-61,123.2560 -62,424.8630 -75,366.7140 -58,982.6680 -66,052.2640
Net Income after Non-Controlling/Minority Interests
-61,123.2560 -62,424.8630 -75,366.7140 -58,982.6680 -66,052.2640
Other Adjustments to Net Income Available to Common Stockholders
0 -- -- -- --
Net Income Available to Common Stockholders
-61,123.2560 -62,424.8630 -75,366.7140 -58,982.6680 -66,052.2640
Diluted Net Income Available to Common Stockholders
-61,123.2560 -62,424.8630 -75,366.7140 -58,982.6680 -66,052.2640
Basic EPS
-0.70 -1.79 -4.06 -4.72 -6.20
Diluted EPS
-0.70 -1.79 -4.06 -4.72 -6.20
Basic Weighted Average Shares Outstanding
81,722.1740 34,796.1200 18,548.8130 12,508.8170 10,603.9740
Diluted Weighted Average Shares Outstanding
81,722.1740 34,796.1200 18,548.8130 12,508.8170 10,603.9740
Income Statement, Supplemental
EBIT
-62,503.4770 -63,783.3020 -73,113.1000 -57,420.1200 -64,562.0080
EBITDA
-62,399.4580 -63,666.2500 -72,999.2410 -57,375.9320 -64,357.3140
Normalized EBITDA
-51,111.1200 -91,709.6080 -103,795.0060 -47,546.1730 -55,203.9850
Normalized Income
-50,114.9026 -89,795.1804 -99,695.3683 -51,217.1584 -58,821.1341
Total Unusual Items
11,288.3380 -28,043.3580 -30,795.7650 9,829.7590 9,153.3290
9/30/2022 - 6/14/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: